Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SB939 in recurrent or metastatic castration-resistant prostate cancer
NCT01075308Phase 2Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Jun 2010
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pracinostat in prostate cancer (PCa), sponsored by Canadian Cancer Trials Group. Started Jun 2010; status: completed.
02
Drugs
pracinostat
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01075308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01075308.